FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic

FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic

The prevalence of obesity or metabolic syndrome is increasing worldwide (globally metabodemic). Approximately 25% of the adult general population is suffering from nonalcoholic fatty liver disease (NAFLD), which has become a serious health problem. In 2020, global experts suggested that the nomencla...

Full description

Bibliographic Details
Main Authors:	Yoshio Sumida, Masashi Yoneda, Katsutoshi Tokushige, Miwa Kawanaka, Hideki Fujii, Masato Yoneda, Kento Imajo, Hirokazu Takahashi, Yuichiro Eguchi, Masafumi Ono, Yuichi Nozaki, Hideyuki Hyogo, Masahiro Koseki, Yuichi Yoshida, Takumi Kawaguchi, Yoshihiro Kamada, Takeshi Okanoue, Atsushi Nakajima, Japan Study Group of NAFLD (JSG-NAFLD)
Format:	Article
Language:	English
Published:	MDPI AG 2021-02-01
Series:	Life
Subjects:	hepatic fibrosis hepatocellular carcinoma vibration-controlled transient elastography nonalcoholic fatty liver disease type 2 diabetes metabolic-dysfunction-associated fatty liver disease
Online Access:	https://www.mdpi.com/2075-1729/11/2/143

Similar Items

Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
by: Asako Nogami, et al.
Published: (2023-02-01)

Outcomes of fatty liver disease with and without metabolic comorbidities and risk factors for mortality
by: Yuri Ogasawara, et al.
Published: (2023-06-01)

Distribution of FIB-4 index in the general population: analysis of 75,666 residents who underwent health checkups
by: Aya Sugiyama, et al.
Published: (2022-05-01)

Fatty Liver, and Not Visceral Fat, Is More Associated with Liver Fibrosis and Diabetes in Non-Obese Japanese Individuals: A Cross-Sectional Study
by: Noriyo Urata, et al.
Published: (2020-09-01)

Eradication of hepatitis C virus with direct‐acting antivirals improves glycemic control in diabetes: A multicenter study
by: Hirokazu Takahashi, et al.
Published: (2021-02-01)

The Current View of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma
by: Tomomi Kogiso, et al.
Published: (2021-01-01)

The Appropriate Opportunity for Evaluating Liver Fibrosis by Using the FIB-4 Index in Patients with Nonalcoholic Fatty Liver Disease in Japan
by: Yuya Seko, et al.
Published: (2020-10-01)

New FIB-4 and NFS cutoffs to guide sequential non-invasive assessment of liver fibrosis by magnetic resonance elastography in NAFLD
by: Louise Torres, et al.
Published: (2023-01-01)

Comparison of long‐term prognosis between non‐obese and obese patients with non‐alcoholic fatty liver disease
by: Michihiro Iwaki, et al.
Published: (2022-10-01)

Prevalence of fatty liver disease after liver transplantation and risk factors for recipients and donors
by: Kentaro Horiuchi, et al.
Published: (2022-03-01)

Assessing Liver Fibrosis Using the FIB4 Index in the Community Setting
by: Albert Blanco-Grau, et al.
Published: (2021-11-01)

Validation of Noninvasive Markers for HCC Risk Stratification in 1389 Patients With Biopsy-proven NAFLD
by: Hidenori Toyoda, et al.
Published: (2023-01-01)

Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study
by: Yasushi Honda, et al.
Published: (2017-08-01)

Inter-platform reproducibility of ultrasound-based fat fraction for evaluating hepatic steatosis in nonalcoholic fatty liver disease
by: Sun Kyung Jeon, et al.
Published: (2024-02-01)

Assessment of the inter-platform reproducibility of ultrasound attenuation examination in nonalcoholic fatty liver disease
by: Sun Kyung Jeon, et al.
Published: (2022-04-01)

Multifocal fatty liver nodules mimicking a metastatic disease: A case report
by: Huy Quang Duong, et al.
Published: (2024-03-01)

Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study
by: Michihiro Iwaki, et al.
Published: (2024-04-01)

Involvement of Periodontal Disease in the Pathogenesis and Exacerbation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis: A Review
by: Takashi Kobayashi, et al.
Published: (2023-03-01)

Association of C-reactive protein with histological, elastographic, and sonographic indices of non-alcoholic fatty liver disease in individuals with severe obesity
by: Tannaz Jamialahmadi, et al.
Published: (2023-04-01)

Value of screening for nonalcoholic fatty liver disease in hyperuricemic patients with normal body mass index by two-dimensional ultrasound: Upper Egypt experience
by: Amro M Hassan, et al.
Published: (2020-01-01)

Elastography Techniques for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
by: Yasushi Honda, et al.
Published: (2020-06-01)

Quantitative ultrasound radiofrequency data analysis for the assessment of hepatic steatosis using the controlled attenuation parameter as a reference standard
by: Sun Kyung Jeon, et al.
Published: (2021-01-01)

Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation on Non-Alcoholic Fatty Liver: A Systematic Review and Meta-Analysis
by: Cheng-Han Lee, et al.
Published: (2020-09-01)

Prediction of Nonalcoholic Fatty Liver Disease Using Noninvasive and Non-Imaging Procedures in Japanese Health Checkup Examinees
by: Kenichiro Murayama, et al.
Published: (2021-01-01)

A comparison of NAFLD and MAFLD diagnostic criteria in contemporary urban healthy adults in China: a cross-sectional study
by: Qiling Liu, et al.
Published: (2022-11-01)

Comparison of liver enzymes and sonological grading in nonalcoholic fatty liver
by: Bishnu Jwarchan, et al.
Published: (2020-03-01)

Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
by: Yoshio Sumida, et al.
Published: (2020-08-01)

The independent effect of exercise on biopsy-proven non-alcoholic fatty liver disease: A systematic review
by: George Chen, et al.
Published: (2023-02-01)

Identification of key genes and pathways in mild and severe nonalcoholic fatty liver disease by integrative analysis
by: Jin Feng, et al.
Published: (2021-12-01)

<b>Analytical methods for evaluation of the fatty acid metabolism in rat liver
by: Eduardo Hideo Gilglioni, et al.
Published: (2018-11-01)

Correlational study of nonalcoholic fatty liver disease diagnosed by ultrasonography with lipid profile and body mass index in adult nepalese population
by: Umesh P Khanal, et al.
Published: (2019-01-01)

Noninvasive assessment of hepatic steatosis using a pathologic reference standard: comparison of CT, MRI, and US-based techniques
by: Jae Seok Bae, et al.
Published: (2022-04-01)

Non-alcoholic fatty liver disease: A review with clinical and pathological correlation
by: Yen-Ying Chen, et al.
Published: (2021-01-01)

Hepatocellular carcinoma in nonalcoholic fatty liver disease with or without cirrhosis: a population-based study
by: Kanokwan Pinyopornpanish, et al.
Published: (2021-10-01)

Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs
by: Saori Takamura, et al.
Published: (2022-04-01)

The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease
by: Hideki Fujii, et al.
Published: (2020-05-01)

Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
by: Kuei-Chuan Lee, et al.
Published: (2023-01-01)

Patophysiology of nonalcoholic fatty liver disease
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019-09-01)

Patophysiology of nonalcoholic fatty liver disease
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019-09-01)

Impact of variations in fatty liver on sonographic detection of focal hepatic lesions originally identified by CT
by: Size Wu, et al.
Published: (2016-01-01)